Stocks · Health care · Pharmaceutical Preparations

LIGAND PHARMACEUTICALS INC

LGND Clue Score50
United States Fiscal year ends December CIK 0000886163 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Jason Aryeh
2 Nov 2026
Director
Sell
700
$320.43
$224.30K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$320.49
$16.02K
Jason Aryeh
30 Oct 2026
Director
Sell
1,209
$320.42
$387.38K
Jason Aryeh
30 Oct 2026
Director
Sell
52
$320.24
$16.65K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$318.23
$15.91K
Jason Aryeh
30 Oct 2026
Director
Sell
50
$317.74
$15.89K

What was left out

Form 4 filings counted 3
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 13
Sales at will 6
Transactions with no price 0
Shares from compensation/vesting 5,000
History held since 29 Sep 2006